FrancophonIA/ELRC3.0 huggingface dataset:
English: The safety and efficacy of Pegfilgrastim Mundipharma administration in de novo AML patients aged < 55 years with cytogenetics t (15;17) have not been established.
Slovenian: Varnost in učinkovitost uporabe zdravila Pegfilgrastim Mundipharma pri bolnikih z de novo AML, mlajših od 55 let in s citogenetiko t(15;17), nista ugotovljeni.
English: Splenomegaly and splenic ruptura
Slovenian: Splenomegalija in ruptura vranice
English: The usual dose is one 6 mg subcutaneous injection (injection under your skin) using a pre-filled syringe and it should be given at least 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle.
Slovenian: Običajni odmerek je ena 6-miligramska subkutana injekcija (podkožna injekcija) z uporabo napolnjene injekcijske brizge, ki jo morate prejeti vsaj 24 ur po zadnjem odmerku kemoterapije na koncu vsakega cikla kemoterapije.
English: Each pre-filled syringe contains 30 mg sorbitol (E420).
Slovenian: Ena napolnjena injekcijska brizga vsebuje 30 mg sorbitola (E 420).
English: Rare side effects (may affect up to 1 in 1,000 people) - Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body), see section 2.
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov) - vnetje aorte (velike žile, ki prenaša kri od srca po telesu), glejte poglavje 2.
English: Pegfilgrastim Mundipharma is used in adult patients to reduce the duration of neutropenia (low white blood cell count) and the occurrence of febrile neutropenia (low white blood cell count with a fever) which can be caused by the use of cytotoxic chemotherapy (medicines that destroy rapidly growing cells).
Slovenian: Zdravilo Pegfilgrastim Mundipharma se uporablja pri odraslih bolnikih za skrajšanje trajanja nevtropenije (zmanjšano število belih krvničk) in zmanjševanje pojavljanja febrilne nevtropenije (zmanjšano število belih krvničk z zvišano telesno temperaturo), ki ju lahko povzroča uporaba citotoksične kemoterapije (zdravila, ki uničujejo hitro rastoče celice).
English: With the exception of the youngest age group (0-5 years), the mean AUC in paediatric subjects appeared similar to that for adult patients with high-risk stage II-IV breast cancer and receiving 100 μg/kg pegfilgrastim after the completion of doxorubicin/docetaxel (see sections 4.8 and 5.1).
Slovenian: Razen v najmlajši starostni skupini (od 0 do 5 let) je bila povprečna AUC pri pediatričnih bolnikih podobna kot pri odraslih bolnikih z visoko tveganim stadijem II-IV raka dojke, ki so dobili 100 μg/kg pegfilgrastima po dokončanju doksorubicina/docetaksela (glejte poglavji 4.8 in 5.1).
English: 6.6 Special precautions for disposal and other handling Before administration, Pegfilgrastim Mundipharma solution should be inspected visually for particulate matter.
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje Pred uporabo morate raztopino zdravila Pegfilgrastim Mundipharma pregledati glede vidnih delcev.
English: - Stevens-Johnson syndrome, which can appear as reddish target-like or circular patches often with central blisters on the trunk, skin peeling, ulcers of mouth, throat, nose, genitals and eyes and can be preceded by fever and flu-like symptoms.
Slovenian: - krvavitev iz pljuč (pljučna krvavitev) - Stevens-Johnsonov sindrom, ki se lahko pojavi kot rdečkaste lise v obliki tarče ali krožne lise na trupu, pogosto z mehurčki na sredini, luščenje kože, razjede v ustih, grlu, nosu, genitalijah in očeh, pred tem pa se lahko pojavijo vročina in gripi podobni simptomi.
English: Uncommon side effects (may affect up to 1 in 100 people): - allergic-type reactions, including redness and flushing, skin rash, and raised areas of the skin that itch.
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov): - reakcije alergijske vrste, vključno s pordelostjo in zardevanjem, izpuščajem na koži in dvignjenimi predeli kože, ki srbijo.
English: - Sweet's syndrome (plum-coloured, raised, painful lesions on the limbs and sometimes the face and neck with fever) has occurred but other factors may play a role.
Slovenian: - Sweetov sindrom (izbočene, boleče spremembe slivove barve na okončinah in včasih tudi na obrazu in vratu z zvišano telesno temperaturo), vendar tu lahko vplivajo tudi drugi dejavniki.
English: Single doses of 300 μg/kg have been administered subcutaneously to a limited number of healthy volunteers and patients with non-small cell lung cancer without serious adverse reactions.
Slovenian: Omejeno število zdravih prostovoljcev in bolnikov z nedrobnoceličnim pljučnim rakom je prejelo subkutane posamične odmerke 300 μg/kg brez resnih neželenih reakcij.
English: The symptoms can include fever, abdominal pain, malaise, back pain and increased inflammatory markers.
Slovenian: Simptomi lahko vključujejo zvišano telesno temperaturo, bolečine v trebuhu, slabo počutje, bolečine v hrbtu in zvišane vrednosti vnetnih označevalcev.
English: In a placebo-controlled, double blind study in patients with breast cancer the effect of pegfilgrastim on the incidence of febrile neutropenia was evaluated following administration of a chemotherapy regimen associated with a febrile neutropenia rate of 10-20 % (docetaxel 100 mg/m2 every 3 weeks for 4 cycles).
Slovenian: V dvojno slepi, s placebom kontrolirani študiji pri bolnicah z rakom na dojki so ocenili učinek pegfilgrastima na incidenco febrilne nevtropenije po uporabi takšne sheme kemoterapije, ki je povezana z 10-20 % deležem febrilne nevtropenije (docetaksel 100 mg/m2 vsake 3 tedne za 4 cikluse).
English: Do not shake Pegfilgrastim Mundipharma vigorously as this may affect its activity.
Slovenian: Zdravila Pegfilgrastim Mundipharma ne smete močno stresati, ker to lahko vpliva na njegovo delovanje.
English: These could be symptoms of an uncommon (may affect up to 1 in 100 people) condition called “Capillary Leak Syndrome” which causes blood to leak from the small blood vessels into your body and needs urgent medical attention.
Slovenian: To so lahko simptomi občasne motnje (pojavi se lahko pri do 1 od 100 oseb), imenovane “sindrom kapilarne prepustnosti”, ki povzroči puščanje krvi iz drobnih krvnih žilic v telesu, in zahteva nujno zdravniško pomoč.
English: Do not administer Pegfilgrastim Mundipharma to patients with a history of hypersensitivity to pegfilgrastim or filgrastim.
Slovenian: Zdravila Pegfilgrastim Mundipharma ne dajajte bolnikom z anamnezo preobčutljivosti na pegfilgrastim ali filgrastim.
English: Very common side effects (may affect more than 1 in 10 people): - bone pain.
Slovenian: Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov): - bolečine v kosteh.
English: Do not recycle pre-filled syringes or throw them into household waste.
Slovenian: Napolnjenih injekcijskih brizg ne smete reciklirati ali jih odvreči med gospodinjske odpadke.
English: The safety and efficacy of Pegfilgrastim Mundipharma have not been investigated in patients with myelodysplastic syndrome, chronic myelogenous leukaemia, and in patients with secondary AML; therefore, it should not be used in such patients.
Slovenian: Varnost in učinkovitost zdravila Pegfilgrastim Mundipharma nista raziskani pri bolnikih z mielodisplastičnim sindromom, kronično mielogeno levkemijo in sekundarno AML, zato ga pri takšnih bolnikih ne smete uporabljati.
English: Granulocyte-colony stimulating factor can promote growth of myeloid cells in vitro and similar effects may be seen on some non-myeloid cells in vitro.
Slovenian: Granulocitne kolonije spodbujajoči faktor lahko spodbudi rast mieloidnih celic in vitro; podobni učinki bi se lahko pojavili pri nekaterih nemieloidnih celicah in vitro.
English: The safety and efficacy of Pegfilgrastim Mundipharma for the mobilisation of blood progenitor cells in patients or healthy donors has not been adequately evaluated.
Slovenian: Druga opozorila Varnosti in učinkovitosti zdravila Pegfilgrastim Mundipharma za mobilizacijo matičnih krvotvornih celic pri bolnikih ali zdravih dajalcih niso primerno ovrednotili.
English: Pegfilgrastim Mundipharma has not been tested in pregnant women.
Slovenian: Zdravila Pegfilgrastim Mundipharma pri nosečnicah niso preskusili.
English: - are planning to have a baby.
Slovenian: - ste noseči,
English: Important: read the package leaflet before handling pre-filled syringe
Slovenian: Pomembno: Pred ravnanjem z napolnjeno injekcijsko brizgo preberite priloženo navodilo!
English: România Egis Pharmaceuticals PLC România Tel: +40
Slovenian: Egis Pharmaceuticals PLC România Tel: +40 21 412 00 17
English: The safety and efficacy of Pegfilgrastim Mundipharma have not been investigated in patients receiving high dose chemotherapy.
Slovenian: Varnosti in učinkovitosti zdravila Pegfilgrastim Mundipharma niso raziskovali pri bolnikih, ki prejemajo kemoterapijo v velikih odmerkih.
English: This medicine contains less than 1 mmol (23 mg) sodium per 6 mg dose, that is to say essentially ‘sodium-free'.
Slovenian: To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 6 mg odmerek, kar v bistvu pomeni "brez natrija".
English: Sodium acetate* Sorbitol (E 420)
Slovenian: sorbitol (E 420)
English: Capillary leak syndrome, which can be life-threatening if treatment is delayed, has been reported as uncommon (≥ 1/1,000 to < 1/100) in cancer patients undergoing chemotherapy following administration of granulocyte colony-stimulating factors; see section 4.4 and section “Description of selected adverse reactions” below.
Slovenian: Občasno (≥ 1/1.000 do < 1/100) so pri bolnikih z rakom, ki so prejemali kemoterapijo po uporabi granulocitne kolonije spodbujajočega faktorja, poročali o sindromu kapilarne prepustnosti, ki je lahko smrtno nevaren, če ni zdravljen takoj; glejte poglavje 4.4 in poglavje “Opis izbranih neželenih učinkov“ spodaj.
English: Do not remove the needle cap from the pre-filled syringe until you are ready to inject.
Slovenian: Ne odstranite pokrovčka igle z napolnjene injekcijske brizge, dokler niste pripravljeni za injiciranje.
English: Pre-filled syringe (Type I glass), with a bromobutyl rubber stopper and a stainless steel needle with an automatic needle guard.
Slovenian: Napolnjena injekcijska brizga (iz stekla tipa I) z zaporko iz bromobutilne gume in iglo iz nerjavnega jekla z avtomatskim ščitnikom igle.
English: *Produced in Escherichia coli cells by recombinant DNA technology followed by conjugation with polyethylene glycol (PEG).
Slovenian: *Pegfilgrastim izdelujejo s tehnologijo rekombinantne DNA v celicah Escherichia coli, ki ji sledi konjugacija s polietilenglikolom (PEG).
English: Pack size of one pre-filled syringe in a blistered packaging.
Slovenian: Pakiranje z eno napolnjeno injekcijsko brizgo v pretisnem omotu.
English: Solution for injection 1 pre-filled syringe with automatic needle guard (0.6 mL).
Slovenian: 1 napolnjena injekcijska brizga z avtomatskim ščitnikom igle (0,6 ml)
English: Excipients: sodium acetate, sorbitol (E 420), polysorbate 20, and water for injections.
Slovenian: Pomožne snovi: natrijev acetat, sorbitol (E 420), polisorbat 20 in voda za injekcije.
English: No dose change is recommended in patients with renal impairment, including those with end stage renal disease.
Slovenian: Pri bolnikih z okvaro ledvic se spreminjanje odmerka ne priporoča; to velja tudi za bolnike s končno odpovedjo ledvic.
English: The syringe is provided with an automatic needle guard.
Slovenian: Na voljo je napolnjena injekcijska brizga z avtomatičnim ščitnikom igle.
English: Each pack contains 1 pre-filled glass syringe with an attached stainless steel needle and needle cap.
Slovenian: Ena škatla vsebuje 1 napolnjeno stekleno injekcijsko brizgo s pričvrščeno iglo iz nerjavnega jekla in pokrovčkom igle.
English: - if you have sudden signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or trouble breathing these could be signs of a severe allergic reaction.
Slovenian: - če se vam pojavijo nenadni znaki alergije, kot so izpuščaj, srbečica ali koprivnica na koži, otekanje obraza, ustnic, jezika ali drugih delov telesa, kratka sapa, piskajoče ali oteženo dihanje.
English: Sweet's syndrome (acute febrile dermatosis)1,2;
Slovenian: (akutna febrilna dermatoza)1,2; kožni vaskulitis1,2
English: For further instructions on how to inject yourself with Pegfilgrastim Mundipharma, please read the section at the end of this leaflet.
Slovenian: Nadaljnja navodila za samoinjiciranje zdravila Pegfilgrastim Mundipharma si preberite v poglavju na koncu tega navodila za uporabo.
English: What Pegfilgrastim Mundipharma is and what it is used for
Slovenian: Kaj je zdravilo Pegfilgrastim Mundipharma in za kaj ga uporabljamo
English: What Pegfilgrastim Mundipharma looks like and contents of the pack Pegfilgrastim Mundipharma is a clear, colourless solution for injection in a pre-filled syringe (6 mg/0.6 mL).
Slovenian: Zdravilo Pegfilgrastim Mundipharma je bistra, brezbarvna raztopina za injiciranje v napolnjeni injekcijski brizgi (6 mg/0,6 ml).
English: - The other ingredients are sodium acetate, sorbitol (E 420), polysorbate 20 and water for injections.
Slovenian: - Pomožne snovi so natrijev acetat, sorbitol (E 420), polisorbat 20 in voda za injekcije.
English: Pegfilgrastim Mundipharma therapy should be initiated and supervised by physicians experienced in oncology and/or haematology.
Slovenian: 4.2 Odmerjanje in način uporabe Zdravljenje z zdravilom Pegfilgrastim Mundipharma morajo uvesti in nadzorovati zdravniki, izkušeni v onkologiji in/ali hematologiji.
English: Österreich Mundipharma Gesellschaft m.b.H.
Slovenian: Mundipharma Gesellschaft m.b.H.
English: If you become pregnant during Pegfilgrastim Mundipharma treatment, please inform your doctor.
Slovenian: Če med zdravljenjem z zdravilom Pegfilgrastim Mundipharma zanosite, o tem obvestite zdravnika.
English: Permanently discontinue Pegfilgrastim Mundipharma in patients with clinically significant hypersensitivity.
Slovenian: Dokončno prenehajte z zdravljenjem z zdravilom Pegfilgrastim Mundipharma pri bolnikih s klinično signifikantno preobčutljivostjo.
English: Pegfilgrastim Mundipharma is not recommended during pregnancy and in women of childbearing potential not using contraception.
Slovenian: Zdravila Pegfilgrastim Mundipharma ne uporabljajte pri nosečnicah in pri ženskah v rodni dobi, ki ne uporabljajo učinkovite kontracepcije.
English: The incidence of febrile neutropenia was lower for patients randomised to receive pegfilgrastim compared with placebo (1 % versus 17 %, p < 0.001).
Slovenian: Incidenca febrilne nevtropenije je bila nižja pri bolnicah, ki so dobivale pegfilgrastim, kot pri tistih, ki so dobivale placebo (1 % v primerjavi s
English: Concomitant use of Pegfilgrastim Mundipharma with any chemotherapy agent has not been evaluated in patients.
Slovenian: Sočasne uporabe zdravila Pegfilgrastim Mundipharma s katerim koli kemoterapevtskim zdravilom pri bolnikih niso ovrednotili.
English: B Open the tray, peeling away the cover.
Slovenian: Odprite podlogo, tako da z nje odlepite pokrivno folijo.
English: There is insufficient information on the excretion of pegfilgrastim/metabolites in human milk a risk to the newborns/infants cannot be excluded.
Slovenian: Ni dovolj podatkov o izločanju pegfilgrastima/presnovkov v materino mleko.
English: Serious allergic reactions, including anaphylaxis can occur in patients receiving pegfilgrastim (uncommon) (see section 4.4).
Slovenian: Bolnikom, ki prejemajo pegfilgrastim, se lahko pojavijo resne alergijske reakcije, vključno z anafilaksijo (občasni) (glejte poglavje 4.4).
English: - if you experience an allergic reaction including weakness, drop in blood pressure, difficulty breathing, swelling of the face (anaphylaxis), redness and flushing, skin rash and areas of the skin that itch - if you experience a cough, fever and difficulty breathing.
Slovenian: - če se vam pojavi alergijska reakcija, vključno s šibkostjo, padcem krvnega tlaka, težavami z dihanjem, otekanjem obraza (anafilaksa), pordelostjo in navali vročine, izpuščajem na koži in predeli kože, ki srbijo.
English: SN:
Slovenian: SN NN
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Slovenian: Podrobni podatki o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu/
English: Pegfilgrastim Mundipharma is a biosimilar medicinal product.
Slovenian: Zdravilo Pegfilgrastim Mundipharma je podobno biološko zdravilo.
English: Nausea1
Slovenian: AST1
English: Step 1: Prepare A Remove the pre-filled syringe tray from the package and gather the supplies needed for your injection: alcohol wipes, a cotton ball or gauze pad, a plaster and a sharps disposal container (not included).
Slovenian: potrebno za injiciranje: alkoholne zložence, kosem vate ali zloženec gaze, obliž in vsebnik za ostre odpadke (ni priloženo).
English: Limited clinical data suggest a comparable effect on time to recovery of severe neutropenia for pegfilgrastim to filgrastim in patients with de novo acute myeloid leukaemia (AML) (see section 5.1).
Slovenian: Pri bolnikih z de novo akutno mieloidno levkemijo (AML) omejeni klinični podatki kažejo primerljiv učinek pegfilgrastima in filgrastima na čas do okrevanja po hudi nevtropeniji (glejte poglavje 5.1).
English: Other medicines and Pegfilgrastim Mundipharma
Slovenian: Druga zdravila in zdravilo Pegfilgrastim Mundipharma
English: The injections should be given into the thigh, abdomen or upper arm. For instructions on handling of the medicinal product before administration, see section 6.6.
Slovenian: Za navodila glede ravnanja z zdravilom pred dajanjem glejte poglavje 6.6.
English: (47.9 ± 22.5 μg·hr/mL) than older children aged 6-11 years and 12-21 years (22.0 ± 13.1 μg·hr/mL and 29.3 ± 23.2 μg·hr/mL, respectively) (see section 5.1).
Slovenian: V najmlajši starostni skupini (od 0 do 5 let) je bila povprečna izpostavljenost pegfilgrastimu (AUC) (± standardni odklon) večja (47,9 ± 22,5 μg h/ml) kot med otroci, starimi od 6 do 11 (22,0 ± 13,1 μg h/ml) in od 12 do 21 let (29,3 ± 23,2 μg h/ml) (glejte poglavje 5.1).
English: Pegfilgrastim Mundipharma is injected subcutaneously.
Slovenian: Zdravilo Pegfilgrastim Mundipharma se injicira subkutano.
English: Solution for injection Clear, colourless solution for injection.
Slovenian: raztopina za injiciranje bistra, brezbarvna raztopina za injiciranje
English: One 6 mg dose (a single pre-filled syringe) of Pegfilgrastim Mundipharma is recommended for each chemotherapy cycle, given at least 24 hours after cytotoxic chemotherapy.
Slovenian: Za vsak cikel kemoterapije priporočajo en 6-miligramski odmerek (eno napolnjeno injekcijsko brizgo) zdravila Pegfilgrastim Mundipharma, ki je dana vsaj 24 ur po citotoksični kemoterapiji.
English: If you forget to inject Pegfilgrastim Mundipharma If you have forgotten a dose of Pegfilgrastim Mundipharma, you should contact your doctor to discuss when you should inject the next dose.
Slovenian: Če ste si pozabili injicirati zdravilo Pegfilgrastim Mundipharma Če ste pozabili odmerek zdravila Pegfilgrastim Mundipharma, se posvetujte z zdravnikom glede tega,
English: Generally asymptomatic cases of splenomegaly and cases of splenic rupture, including some fatal cases, have been reported following administration of pegfilgrastim (see section 4.8).
Slovenian: Po uporabi pegfilgrastima so poročali o v splošnem asimptomatskih primerih splenomegalije in o primerih rupture vranice, vključno z nekaterimi smrtnimi primeri (glejte poglavje 4.8).
English: Severe skin reactions (Stevens-Johnson syndrome) have been reported with the use of Pegfilgrastim Mundipharma.
Slovenian: Ob uporabi zdravila Pegfilgrastim Mundipharma so poročali o hudih kožnih reakcijah (Stevens-Johnsonov sindrom).
English: - Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported rarely in cancer patients and healthy donors.
Slovenian: - Pri bolnikih z rakom in zdravih darovalcih so redko poročali o vnetju aorte (velike žile, ki prenaša kri od srca po telesu).
English: In one study (n = 157), which used a 6 mg fixed dose of pegfilgrastim the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.8 days compared with 1.6 days in the filgrastim group
Slovenian: V eni študiji (n = 157), v kateri so uporabili stalni odmerek 6 mg pegfilgrastima, je bilo srednje trajanje nevtropenije 4. stopnje v skupini s pegfilgrastimom 1,8 dni, v skupini s filgrastimom pa 1,6 dni (razlika 0,23 dneva, 95 % IZ je -0,15, 0,63).
English: Injection site reactions2
Slovenian: reakcije na mestu injiciranja2
English: Hypersensitivity, including anaphylactic reactions, occurring on initial or subsequent treatment have been reported in patients treated with pegfilgrastim.
Slovenian: Pri bolnikih, zdravljenih s pegfilgrastimom, so poročali o preobčutljivosti, vključno z anafilaktičnimi reakcijami, ki se pojavijo med začetnim ali nadaljnjim zdravljenjem.
English: Remove and save the pre-filled syringe label
Slovenian: Odstranite in shranite nalepko z napolnjene injekcijske brizge.
English: Manufacturer PharmaKorell GmbH Marie-Curie-Strasse 8
Slovenian: Proizvajalec PharmaKorell GmbH Marie-Curie-Strasse 8 D-79539 Lörrach Nemčija
English: Stop using Pegfilgrastim Mundipharma if you develop these symptoms and contact your doctor or seek medical attention immediately.
Slovenian: Če se vam pojavijo ti simptomi, prenehajte uporabljati zdravilo Pegfilgrastim Mundipharma in se nemudoma posvetujte z zdravnikom ali poiščite zdravniško pomoč.
English: Do not put the needle cap back on used pre-filled syringes
Slovenian: Pokrovčka igle ne nameščajte nazaj na uporabljeno injekcijsko brizgo.
English: How to use Pegfilgrastim Mundipharma
Slovenian: Kako uporabljati zdravilo Pegfilgrastim Mundipharma
English: This can be a sign of Acute Respiratory Distress Syndrome (ARDS) - if you have any of the following or combination of the following side effects: - swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness.
Slovenian: - če se vam pojavi kateri od naslednjih neželenih učinkov ali kombinacija teh neželenih učinkov: - oteklost ali zabuhlost, ki jo lahko spremlja manj pogostejše odvajanje urina, težko dihanje, oteklost trebuha in občutek polnosti ter splošen občutek utrujenosti.
English: What Pegfilgrastim Mundipharma contains - The active substance is pegfilgrastim.
Slovenian: Kaj vsebuje zdravilo Pegfilgrastim Mundipharma - Učinkovina je pegfilgrastim.
English: Each pre-filled syringe contains 6 mg of pegfilgrastim* in 0.6 mL solution for injection.
Slovenian: Ena napolnjena injekcijska brizga vsebuje 6 mg pegfilgrastima* v 0,6 ml raztopine za injiciranje.
English: Upper part of your thigh.
Slovenian: • zgornji del stegna.
English: In most cases aortitis was diagnosed by CT scan and generally resolved after withdrawal of G-CSF (see section 4.8).
Slovenian: Aortitis so v večini primerov diagnosticirali s slikanjem s CT, na splošno pa je minil po ukinitvi
English: EGIS Pharmaceuticals PLC parstavniecibas Tel: + 371 676 13 859 info@egis.lv
Slovenian: EGIS Pharmaceuticals PLC parstavniecibas Tel: + 371 676 13 859
English: If you use more Pegfilgrastim Mundipharma than you should If you use more Pegfilgrastim Mundipharma than you should contact your doctor, pharmacist or nurse.
Slovenian: Če ste uporabili večji odmerek zdravila Pegfilgrastim Mundipharma, kot bi smeli Če uporabite več zdravila Pegfilgrastim Mundipharma, kot bi smeli, se posvetujte z zdravnikom,
English: If you develop or are likely to develop cancers of the blood, you should not use Pegfilgrastim Mundipharma, unless instructed by your doctor.
Slovenian: Če se vam bodo pojavili ali je verjetno, da se vam bodo pojavili krvni raki, ne smete uporabljati zdravila Pegfilgrastim